pramipexole 1 mg
1 INDICATIONS AND USAGE Pramipexole dihydrochloride tablets is a non-ergot dopamine agonist indicated for the treatment of: Parkinson's disease (PD) (1.1) Moderate-to-severe primary Restless Legs Syndrome (RLS) (1.2) 1.1 Parkinson’s Disease Pramipexole dihydrochloride tablets are indicated for the treatment of Parkinson's disease. 1.2 Restless Legs Syndrome Pramipexole dihydrochloride tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
strides pharma science limited
ROUND WHITE P 5
P 5 ROUND WHITE
Related Pills
pramipexole 1.5 mg
strides pharma science limited
pramipexole 1 mg
strides pharma science limited
24 hr glipizide extended release oral tablet
rising pharmaceuticals, inc.
24 hr glipizide extended release oral tablet
rising pharmaceuticals, inc.
24 hr glipizide extended release oral tablet
rising pharmaceuticals, inc.
ciprofloxacin as ciprofloxacin hydrochloride 500 MG Oral Tablet
Pack Pharmaceuticals, LLC
levothyroxine sodium 25 MCG Oral Tablet
Lannett Company, Inc.
Spironolactone 50 MG Oral Tablet
McKesson Packaging Services Business Unit of
prednisone tablet
proficient rx lp
citalopram 20 MG as citalopram hydrobromide 24.99 MG Oral Tablet
Amneal Pharmaceuticals
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
PRAMIPEXOLE DIHYDROCHLORIDE tablets are available as follows: 0.125 mg: white to off white colored circular tablets, debossed as 'P1' on one side and plain on other side. Bottles of 90 NDC: 64380-746-05 0.25 mg: white to off white colored, oval tablets, debossed as "P2" on one side with break line on both sides. Bottles of 90 NDC: 64380-747-05 Unit dose pack of 100 (10x10) NDC: 64380-747-01 0.5 mg: white to off white colored, oval shaped tablets, debossed as "P3" on one side with break line on both sides. Bottles of 90 NDC: 64380-748-05 Unit dose pack of 100 (10x10) NDC: 64380-748-01 0.75 mg: white to off white colored, oval shaped tablets, debossed as "P4" on one side plain on other side. Bottles of 90 NDC: 64380-749-05 1 mg: white to off white colored circular tablets, debossed as "P5" on one side and break line on both sides. Bottles of 90 NDC: 64380-750-05 Unit dose pack of 100 (10x10) NDC: 64380-750-01 1.5 mg: white to off white colored circular tablets, debossed as "P6" on one side and break line on both sides. Bottles of 90 NDC: 64380-751-05 Unit dose pack of 100(10x10) NDC: 64380-751-01 16.2 Storage and Handling Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°- 86°F) [see USP Controlled Room Temperature]. Protect from light. Store in a safe place out of the reach of children.
More pills like ROUND P 5